Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Testing the Efficacy of Different Dosages of Lercanidipine to Reduce Hypertensive Blood Pressure in Normal Weight and Obese Patients

This study has been completed.
Information provided by:
UCB Pharma Identifier:
First received: September 8, 2005
Last updated: March 7, 2008
Last verified: March 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2005
  Primary Completion Date: August 2005 (Final data collection date for primary outcome measure)